View in EDS HTML Full Text PDF Full Text

A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761® in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.

Saved in:
Bibliographic Details
Title: A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761® in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.
Authors: Matias-Guiu JA; Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, Spain., Arelin K; AES Part of Thermo Fisher Scientific, Leipzig, Germany.; MEDIAN Ambulantes Gesundheitszentrum, Leipzig, Germany., Serrano PJ; Thermo Fisher Scientific, Wilmington, NC, United States., Wacker A; Clinical Research, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany., Sória MG; Clinical Research, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany., Burkart M; Global Medical Affairs, Dr. Schwabe Holding SE & Co. KG, Karlsruhe, Germany., Zifko U; Rudolfinerhaus Private Hospital GmbH, Vienna, Austria.
Source: Frontiers in human neuroscience [Front Hum Neurosci] 2026 Jun 15; Vol. 20, pp. 1658342. Date of Electronic Publication: 2026 Jun 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477954 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5161 (Print) Linking ISSN: 16625161 NLM ISO Abbreviation: Front Hum Neurosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42376237
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761<superscript>®</superscript> in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matias-Guiu+JA%22">Matias-Guiu JA</searchLink>; Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Arelin+K%22">Arelin K</searchLink>; AES Part of Thermo Fisher Scientific, Leipzig, Germany.; MEDIAN Ambulantes Gesundheitszentrum, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Serrano+PJ%22">Serrano PJ</searchLink>; Thermo Fisher Scientific, Wilmington, NC, United States.<br /><searchLink fieldCode="AU" term="%22Wacker+A%22">Wacker A</searchLink>; Clinical Research, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany.<br /><searchLink fieldCode="AU" term="%22Sória+MG%22">Sória MG</searchLink>; Clinical Research, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany.<br /><searchLink fieldCode="AU" term="%22Burkart+M%22">Burkart M</searchLink>; Global Medical Affairs, Dr. Schwabe Holding SE & Co. KG, Karlsruhe, Germany.<br /><searchLink fieldCode="AU" term="%22Zifko+U%22">Zifko U</searchLink>; Rudolfinerhaus Private Hospital GmbH, Vienna, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101477954%22">Frontiers in human neuroscience</searchLink> [Front Hum Neurosci] 2026 Jun 15; Vol. 20, pp. 1658342. <i>Date of Electronic Publication: </i>2026 Jun 15 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101477954 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1662-5161 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216625161%22">16625161 </searchLink><i>NLM ISO Abbreviation: </i>Front Hum Neurosci <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42376237
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fnhum.2026.1658342
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1658342
    Titles:
      – TitleFull: A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761® in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matias-Guiu JA
      – PersonEntity:
          Name:
            NameFull: Arelin K
      – PersonEntity:
          Name:
            NameFull: Serrano PJ
      – PersonEntity:
          Name:
            NameFull: Wacker A
      – PersonEntity:
          Name:
            NameFull: Sória MG
      – PersonEntity:
          Name:
            NameFull: Burkart M
      – PersonEntity:
          Name:
            NameFull: Zifko U
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 06
              Text: 2026 Jun 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1662-5161
          Numbering:
            – Type: volume
              Value: 20
          Titles:
            – TitleFull: Frontiers in human neuroscience
              Type: main
ResultId 1